naphazoline has been researched along with Disease Models, Animal in 7 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the current study was to investigate whether olopatadine and naphazoline hydrochloride reduce allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF." | 7.83 | Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF. ( He, H; Quan, L, 2016) |
| "The aim of the current study was to investigate whether olopatadine and naphazoline hydrochloride reduce allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF." | 3.83 | Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF. ( He, H; Quan, L, 2016) |
| "Both U-46619- and LTD4-induced nasal blockages in sensitized animals were swiftly and completely suppressed by a vasoconstrictor, naphazoline." | 1.33 | Different mechanisms between thromboxane A2- and leukotriene D4-induced nasal blockage in guinea pigs. ( Fujii, M; Kohno, S; Mizutani, N; Nabe, T; Tanaka, Y, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Acar, MF | 1 |
| Sari, S | 1 |
| Dalkara, S | 1 |
| Quan, L | 1 |
| He, H | 1 |
| Tanaka, Y | 1 |
| Mizutani, N | 2 |
| Fujii, M | 1 |
| Nabe, T | 2 |
| Kohno, S | 2 |
| Sasaki, K | 1 |
| Takenaka, H | 1 |
| Elwany, S | 1 |
| Abdel-Salaam, S | 1 |
| Salem, H | 1 |
| Dunn, BJ | 1 |
| Loux, JJ | 1 |
7 other studies available for naphazoline and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Synthesis, in vivo anticonvulsant testing, and molecular modeling studies of new nafimidone derivatives.
Topics: Administration, Oral; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, | 2019 |
Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF.
Topics: Animals; Blotting, Western; Conjunctivitis, Allergic; Cytokines; Disease Models, Animal; Drug Therap | 2016 |
Different mechanisms between thromboxane A2- and leukotriene D4-induced nasal blockage in guinea pigs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Resistance; Animals; Bloo | 2006 |
Nasal hyperresponsiveness to histamine induced by repetitive exposure to cedar pollen in guinea-pigs.
Topics: Administration, Inhalation; Airway Resistance; Allergens; Animals; Atropine; Disease Models, Animal; | 1999 |
Treatment of rhinitis medicamentosa with fluticasone propionate--an experimental study.
Topics: Administration, Intranasal; Androstadienes; Animals; Disease Models, Animal; Drug Hypersensitivity; | 2001 |
Conjunctival temperature: a measure of ocular decongestant and anti-inflammatory activity.
Topics: Administration, Oral; Administration, Topical; Animals; Antazoline; Anti-Inflammatory Agents; Aspiri | 1975 |